Adenotonsillar pathology in mucopolysaccharidoses - lysosomal storage predominates in paracortical CD63+ cells

Virchows Arch. 2024 Jan;484(1):135-140. doi: 10.1007/s00428-023-03662-y. Epub 2023 Oct 3.

Abstract

Despite the adenoids are regularly removed in patients with mucopolysaccharidoses (MPS), the underlying tissue and cellular pathologies remain understudied. We characterized an (immuno)histopathologic and ultrastructural phenotype dominated by lysosomal storage changes in a specific subset of adenotonsillar paracortical cells in 8 MPS patients (3 MPS I, 3 MPS II, and 2 MPS IIIA). These abnormal cells were effectively detected by an antibody targeting the lysosomal membrane tetraspanin CD63. Important, CD63+ storage vacuoles in these cells lacked the monocytes/macrophages lysosomal marker CD68. Such a distinct patterning of CD63 and CD68 was not present in a patient with infantile neurovisceral variant of acid sphingomyelinase deficiency. The CD63+ storage pathology was absent in two MPS I patients who either received enzyme-replacement therapy or underwent hematopoietic stem cells transplantation prior the adenoidectomy. Our study demonstrates novel features of lysosomal storage patterning and suggests diagnostic utility of CD63 detection in adenotonsillar lymphoid tissue of MPS patients.

Keywords: Adenoidectomy; CD63; CD68; Enzyme-replacement therapy; Hematopoietic stem cells transplantation; Mucopolysaccharidoses.

MeSH terms

  • Enzyme Replacement Therapy
  • Humans
  • Lymphoid Tissue / pathology
  • Lysosomes
  • Mucopolysaccharidoses* / diagnosis
  • Mucopolysaccharidoses* / drug therapy
  • Mucopolysaccharidoses* / genetics
  • Tetraspanin 30

Substances

  • CD63 protein, human
  • Tetraspanin 30